Comparing Injection Treatments for Tennis Elbow

Launched by WRIGHTINGTON, WIGAN AND LEIGH NHS FOUNDATION TRUST · Jun 11, 2019

Keywords

ClinConnect Summary

This clinical trial is looking at different injection treatments for tennis elbow, a common condition that causes pain on the outer side of the elbow due to overuse of the arm muscles. The study aims to compare the effectiveness of two types of therapeutic injections—platelet-rich plasma and hyaluronic acid—along with a standard physiotherapy program, against a control injection that doesn't contain any medicine. Researchers want to see how these treatments affect pain and function in people with tennis elbow over a period of 12 months.

To participate, individuals need to be at least 18 years old and have been diagnosed with tennis elbow for more than three months. They should also be able to provide informed consent. Participants will receive a structured physiotherapy program and will randomly be assigned to one of the three injection groups. They will be followed closely for a year to assess their progress and improvement in symptoms. This study is important because it aims to provide more evidence on the best treatment options for tennis elbow, which can help guide future decisions for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Invitations to participate in the study will be extended to male and female patients, 18 years and above, referred to the Orthopaedic Departments who receive a diagnosis of Lateral Epicondyle Tendinosis (with or without degenerative changes) with symptoms present for \> 3 months, whose symptoms and clinical evaluation warrant the prescription of a peri-tendinous injection to relieve symptoms and who are competent to give informed consent.
• Exclusion Criteria:
• • Absence of tenderness at the lateral epicondyle.
• • Congenital or traumatic bio-mechanical deformities of Elbow complex.
• • Previous Corticosteroidal, Local Anaesthetic, PRP or Hyaluronic Acid injections to target elbow within the last three months.
• • Known hypersensitivity to PRP, Hyaluronic acid or any excipients associated with any of the prescribed injections.
• • Known contraindication to any treatments constituting normal/appropriate therapy in the view of the Consulting clinician including local infection
• • Ipsilateral arm pathology severe enough to cause confusion of localised pain perception.
• • Pregnant or lactating women
• • Pain score less than 4/10
• • Patients commenced on medication for the treatment of anxiety or depression within the last 6 weeks
• • Previous involved in research in last 12 months
• • Any progressive, degenerative neuromuscular disorder